Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improv...
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy
About this item
Full title
Author / Creator
Publisher
Australia: Ivyspring International Publisher
Journal title
Language
English
Formats
Publication information
Publisher
Australia: Ivyspring International Publisher
Subjects
More information
Scope and Contents
Contents
Immunotherapy, an attractive option for cancer treatment, necessitates the direct stimulation of immune cells
and the simultaneous effective inhibition of immunosuppressive tumor microenvironments.
: In the present study, we developed an injectable PEG-
-poly(L-alanine) hydrogel for co-delivery of a tumor vaccine and dual immune checkpoint...
Alternative Titles
Full title
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6531311
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6531311
Other Identifiers
ISSN
1838-7640
E-ISSN
1838-7640
DOI
10.7150/thno.30577
